# Question 28

**Type:** Basic Query - Pathway Analysis

**Question:** "What percentage of glioblastoma patients have alterations in RB pathway genes (CDKN2A, CDK4, RB1)?"

**Answer:**

**URL**: https://www.cbioportal.org/results/oncoprint?Action=Submit&RPPA_SCORE_THRESHOLD=2.0&Z_SCORE_THRESHOLD=2.0&cancer_study_list=gbm_tcga_pan_can_atlas_2018&case_set_id=gbm_tcga_pan_can_atlas_2018_cnaseq&data_priority=0&gene_list=CDKN2A%0ACDK4%0ARB1&geneset_list=%20&genetic_profile_ids_PROFILE_COPY_NUMBER_ALTERATION=gbm_tcga_pan_can_atlas_2018_gistic&genetic_profile_ids_PROFILE_MUTATION_EXTENDED=gbm_tcga_pan_can_atlas_2018_mutations&profileFilter=0&tab_index=tab_visualize

This URL takes you to the OncoPrint view for the TCGA PanCancer Atlas 2018 Glioblastoma study, querying CDKN2A, CDK4, and RB1. 

On this page, you'll see:
- A visual representation of alterations across all patients in the cohort
- The percentage of patients with alterations in these genes (displayed at the top of the OncoPrint)
- Individual alteration types (mutations, amplifications, deletions) for each gene
- Summary statistics showing how many patients are affected by at least one alteration in these RB pathway genes

You can explore the data further using the various tabs (Cancer Types Summary, Mutual Exclusivity, Plots, etc.) to analyze these alterations in more detail.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 7.883551086997613
- **agent_type**: cbio-nav-null

### Usage
- **input_tokens**: 562
- **output_tokens**: 392
- **total_tokens**: 954
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 01:37:06*